| 臺大學術典藏 |
2020-03-05T12:22:25Z |
Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer
|
Lin Y.-L.; Liau J.-Y.; SHAN-CHI YU; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-03-05T12:22:25Z |
KRAS Mutation Is a Predictor of Oxaliplatin Sensitivity in Colon Cancer Cells
|
Liau J.-Y.; SHAN-CHI YU; Ou D.-L.; Lin L.-I.; Tseng L.-H.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.; Lin Y.-L. |
| 臺大學術典藏 |
2020-03-05T07:52:33Z |
Ovarian and endometrial endometrioid adenocarcinomas have distinct profiles of microsatellite instability, PTEN expression, and ARID1A expression
|
Huang H.-N.; Lin M.-C.; Tseng L.-H.; Chiang Y.-C.; Lin L.-I.; Lin Y.-F.; Huang H.-Y.; KUAN-TING KUO |
| 臺大學術典藏 |
2020-03-05T07:31:48Z |
Traditional serrated adenoma has two pathways of neoplastic progression that are distinct from the sessile serrated pathway of colorectal carcinogenesis
|
JIA-HUEI TSAI; Liau J.-Y.; Lin Y.-L.; Lin L.-I.; Cheng Y.-C.; Cheng M.-L.; Jeng Y.-M. |
| 臺大學術典藏 |
2020-03-05T07:31:48Z |
Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients
|
Lin Y.-.;Liang Y.-H.;Jia-Huei Tsai;Liau J.-Y.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Lin L.-I.;Tseng L.-H.;Chang Y.-L.;Yeh K.-H.;Cheng A.-L.; Lin Y.-.; Liang Y.-H.; JIA-HUEI TSAI; Liau J.-Y.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Lin L.-I.; Tseng L.-H.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-03-05T07:31:46Z |
Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations
|
Liang Y.-H.;Lin Y.-L.;Liau J.-Y.;Jia-Huei Tsai;Liang J.-T.;Lin B.-R.;Hung J.-S.;Tseng L.-H.;Lin L.-I.;Chang Y.-L.;Cheng A.-L.;Yeh K.-H.; Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Yeh K.-H.; Cheng A.-L.; Chang Y.-L.; Lin L.-I.; Tseng L.-H.; JIA-HUEI TSAI; Liang J.-T.; Lin B.-R.; Hung J.-S. |
| 臺大學術典藏 |
2020-03-05T07:31:45Z |
BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer
|
Chen K.-H.; Lin Y.-L.; Liau J.-Y.; JIA-HUEI TSAI; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-03-05T07:31:45Z |
Frequent BRAF mutation in early-onset colorectal cancer in Taiwan: Association with distinct clinicopathological and molecular features and poor clinical outcome
|
Jia-Huei Tsai;Liau J.-Y.;Lin Y.-L.;Tseng L.-H.;Lin L.-I.;Yeh K.-H.;Jeng Y.-M.; JIA-HUEI TSAI; Liau J.-Y.; Lin Y.-L.; Tseng L.-H.; Lin L.-I.; Yeh K.-H.; Jeng Y.-M. |
| 臺大學術典藏 |
2020-03-05T07:31:44Z |
Traditional serrated adenoma with BRAF mutation is associated with synchronous/metachronous BRAF-mutated serrated lesions
|
JIA-HUEI TSAI; Cheng C.-H.; Chen C.-C.; Lin Y.-L.; Lin L.-I.; Chen M.-L.; Liau J.-Y. |
| 臺大學術典藏 |
2020-03-05T06:28:43Z |
Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer
|
Cheng A.-L.; Yeh K.-H.; Chang Y.-L.; Hung J.-S.; Lin Y.-L.; JAU-YU LIAU; Yu S.-C.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R. |
| 臺大學術典藏 |
2020-03-05T06:28:40Z |
Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients
|
Cheng A.-L.; Chang Y.-L.; Yeh K.-H.; Tseng L.-H.; Lin L.-I.; Hung J.-S.; Lin B.-R.; Liang J.-T.; Lin Y.-.; Liang Y.-H.; Tsai J.-H.; JAU-YU LIAU |
| 臺大學術典藏 |
2020-03-05T06:28:39Z |
Traditional serrated adenoma has two pathways of neoplastic progression that are distinct from the sessile serrated pathway of colorectal carcinogenesis
|
Tsai J.-H.;Jau-Yu Liau;Lin Y.-L.;Lin L.-I.;Cheng Y.-C.;Cheng M.-L.;Jeng Y.-M.; Tsai J.-H.; JAU-YU LIAU; Lin Y.-L.; Lin L.-I.; Cheng Y.-C.; Cheng M.-L.; Jeng Y.-M. |
| 臺大學術典藏 |
2020-03-05T06:28:37Z |
Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations
|
Liang Y.-H.;Lin Y.-L.;Jau-Yu Liau;Tsai J.-H.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Tseng L.-H.;Lin L.-I.;Chang Y.-L.;Cheng A.-L.;Yeh K.-H.; Liang Y.-H.; Lin Y.-L.; JAU-YU LIAU; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Tseng L.-H.; Lin L.-I.; Chang Y.-L.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2020-03-05T06:28:37Z |
Aberrant expression of annexin A10 is closely related to gastric phenotype in serrated pathway to colorectal carcinoma
|
Tsai J.-H.;Lin Y.-L.;Cheng Y.-C.;Chen C.-C.;Lin L.-I.;Tseng L.-H.;Cheng M.-L.;Jau-Yu Liau;Jeng Y.-M.; Tsai J.-H.; Lin Y.-L.; Cheng Y.-C.; Chen C.-C.; Lin L.-I.; Tseng L.-H.; Cheng M.-L.; JAU-YU LIAU; Jeng Y.-M. |
| 臺大學術典藏 |
2020-03-05T06:28:33Z |
Traditional serrated adenoma with BRAF mutation is associated with synchronous/metachronous BRAF-mutated serrated lesions
|
Tsai J.-H.;Cheng C.-H.;Chen C.-C.;Lin Y.-L.;Lin L.-I.;Chen M.-L.;Jau-Yu Liau; Tsai J.-H.; Cheng C.-H.; Chen C.-C.; Lin Y.-L.; Lin L.-I.; Chen M.-L.; JAU-YU LIAU |
| 臺大學術典藏 |
2020-03-05T06:28:33Z |
BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer
|
Chen K.-H.;Lin Y.-L.;Jau-Yu Liau;Tsai J.-H.;Tseng L.-H.;Lin L.-I.;Liang J.-T.;Lin B.-R.;Hung J.-S.;Chang Y.-L.;Yeh K.-H.;Cheng A.-L.; Chen K.-H.; Lin Y.-L.; JAU-YU LIAU; Tsai J.-H.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; Hung J.-S.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-03-05T06:28:33Z |
Frequent BRAF mutation in early-onset colorectal cancer in Taiwan: Association with distinct clinicopathological and molecular features and poor clinical outcome
|
Tsai J.-H.; JAU-YU LIAU; Lin Y.-L.; Tseng L.-H.; Lin L.-I.; Yeh K.-H.; Jeng Y.-M. |
| 臺大學術典藏 |
2020-03-05T06:28:28Z |
CpG Island Methylator Phenotype May Predict Poor Overall Survival of Patients with Stage IV Colorectal Cancer
|
Chen K.-H.;Lin L.-I.;Tseng L.-H.;Lin Y.-L.;Jau-Yu Liau;Tsai J.-H.;Liang J.-T.;Lin B.-R.;Cheng A.-L.;Yeh K.-H.; Chen K.-H.; Lin L.-I.; Tseng L.-H.; Lin Y.-L.; JAU-YU LIAU; Tsai J.-H.; Liang J.-T.; Lin B.-R.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2020-02-25T05:15:28Z |
Oxaliplatin-based chemotherapy might provide longer progression-free survival in KRAS mutant metastatic colorectal cancer
|
Lin Y.-L.; Liau J.-Y.; Yu S.-C.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; JI-SHIANG HUNG; Chang Y.-L.; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-02-25T05:15:26Z |
Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients
|
Liau J.-Y.; Liang J.-T.; Lin B.-R.; JI-SHIANG HUNG; Lin L.-I.; Tseng L.-H.; Chang Y.-L.; Yeh K.-H.; Cheng A.-L.; Lin Y.-.; Liang Y.-H.; Tsai J.-H. |
| 臺大學術典藏 |
2020-02-25T05:15:25Z |
BRAF mutation may have different prognostic implications in early- and late-stage colorectal cancer
|
Chen K.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Tseng L.-H.; Lin L.-I.; Liang J.-T.; Lin B.-R.; JI-SHIANG HUNG; Chang Y.-L.; Yeh K.-H.; Cheng A.-L. |
| 臺大學術典藏 |
2020-02-25T05:15:25Z |
Cetuximab might be detrimental to metastatic colorectal cancer patients with KRAS codon 12 mutations
|
Liang Y.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; Lin B.-R.; JI-SHIANG HUNG; Tseng L.-H.; Lin L.-I.; Chang Y.-L.; Cheng A.-L.; Yeh K.-H. |
| 臺大學術典藏 |
2020-02-24T02:29:11Z |
CpG Island Methylator Phenotype May Predict Poor Overall Survival of Patients with Stage IV Colorectal Cancer
|
Lin L.-I.; Tseng L.-H.; Lin Y.-L.; Liau J.-Y.; Tsai J.-H.; Liang J.-T.; BEEN-REN LIN; Cheng A.-L.; Yeh K.-H.; Chen K.-H.; Chen K.-H.;Lin L.-I.;Tseng L.-H.;Lin Y.-L.;Liau J.-Y.;Tsai J.-H.;Liang J.-T.;Been-Ren Lin;Cheng A.-L.;Yeh K.-H. |
| 臺大學術典藏 |
2020-02-14T08:50:33Z |
Ovarian and endometrial endometrioid adenocarcinomas have distinct profiles of microsatellite instability, PTEN expression, and ARID1A expression
|
Huang H.-N; Lin M.-C; Tseng L.-H; YING-CHENG CHIANG; Lin L.-I; Lin Y.-F; Huang H.-Y; Kuo K.-T. |
| 臺大學術典藏 |
2019-12-24T09:05:42Z |
Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients
|
Tsai C.-H.;Yao C.-Y.;Tien F.-M.;Tang J.-L.;Kuo Y.-Y.;Chiu Y.-C.;Lin C.-C.;Tseng M.-H.;Peng Y.-L.;Liu M.-C.;Liu C.-W.;Yao M.;Lin L.-I.;Chou W.-C.;Chen C.-Y.;Hou H.-A.;Tien H.-F.; Tsai C.-H.; Yao C.-Y.; Tien F.-M.; Tang J.-L.; Kuo Y.-Y.; Chiu Y.-C.; Lin C.-C.; Tseng M.-H.; Peng Y.-L.; Liu M.-C.; Liu C.-W.; Yao M.; Lin L.-I.; Chou W.-C.; Chen C.-Y.; Hou H.-A.; Tien H.-F.; CHIEN-YU CHEN |
| 臺大學術典藏 |
2019 |
CpG Island Methylator Phenotype May Predict Poor Overall Survival of Patients with Stage IV Colorectal Cancer
|
Liau J.-Y.; JIA-HUEI TSAI; Liang J.-T.; Lin B.-R.; Cheng A.-L.; Yeh K.-H.; Lin Y.-L.; Tseng L.-H.; Lin L.-I.; Chen K.-H.; Chen K.-H.;Lin L.-I.;Tseng L.-H.;Lin Y.-L.;Liau J.-Y.;Jia-Huei Tsai;Liang J.-T.;Lin B.-R.;Cheng A.-L.;Yeh K.-H. |
| 臺大學術典藏 |
2019 |
Incorporation of long non-coding RNA expression profile in the 2017 ELN risk classification can improve prognostic prediction of acute myeloid leukemia patients
|
Tien, H.-F.; Hou, H.-A.; Chen, C.-Y.; Lin, C.-C.; Tseng, M.-H.; Peng, Y.-L.; Liu, M.-C.; Liu, C.-W.; Yao, M.; Lin, L.-I.; Chou, W.-C.; Chiu, Y.-C.; Kuo, Y.-Y.; Tang, J.-L.; Tien, F.-M.; Yao, C.-Y.; Tsai, C.-H. |
| 臺大學術典藏 |
2019 |
Cytarabine-resistant FLT3-ITD leukemia cells are associated with TP53 mutation and multiple pathway alterations—possible therapeutic efficacy of cabozantinib
|
Ko Y.-C.; Hu C.-Y.; Liu Z.-H.; HWEI-FANG TIEN; Ou D.-L.; Chien H.-F.; Lin L.-I. |
| 臺大學術典藏 |
2018-09-10T18:07:26Z |
Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome
|
Hou, H.-A.;Tsai, C.-H.;Lin, C.-C.;Chou, W.-C.;Kuo, Y.-Y.;Liu, C.-Y.;Tseng, M.-H.;Peng, Y.-L.;Liu, M.-C.;Liu, C.-W.;Liao, X.-W.;Lin, L.-I.;Yao, M.;Tang, J.-L.;Tien, H.-F.; WEN-CHIEN CHOU; YUAN-YEH KUO; LIANG-IN LIN; CHIEN-CHIN LIN |
| 臺大學術典藏 |
2018-09-10T15:33:22Z |
Frequent BRAF mutation in early-onset colorectal cancer in Taiwan: Association with distinct clinicopathological and molecular features and poor clinical outcome
|
Tsai, J.-H.;Liau, J.-Y.;Lin, Y.-L.;Tseng, L.-H.;Lin, L.-I.;Yeh, K.-H.;Jeng, Y.-M.; Tsai, Jia-Huei; Lan, C; Lan, C; YUNG-MING JENG; JAU-YU LIAU; Chen, SY; Liau, Jau-Yu; Lin, Yu-Lin; Lai, JS; LIANG-IN LIN; Tseng, Li-Hui; Lin, Liang-In; Yeh, Kun-Huei; Jeng, Yung-Ming |
| 臺大學術典藏 |
2018-09-10T06:22:13Z |
Stability of curcumin in buffer solutions and characterization of its degradation products
|
Wang, Y.-J.;Pan, M.-H.;Cheng, A.-L.;Lin, L.-I.;Ho, Y.-S.;Hsieh, C.-Y.;Lin, J.-K; Wang, Y.-J.; Pan, M.-H.; Cheng, A.-L.; Lin, L.-I.; Ho, Y.-S.; Hsieh, C.-Y.; Lin, J.-K; LIANG-IN LIN; ANN-LII CHENG; MIN-HSIUNG PAN |
| 臺大學術典藏 |
2018-09-10T04:17:48Z |
A new codon 31 (-C) mutant resulting in beta zero-thalassemia.
|
Lin, L.I.;Lin, K.S.;Lin, K.H.; KAI-HSIN LIN |
| 臺大學術典藏 |
2018-09-10T03:52:40Z |
The spectrum of β-thalassemia mutations in Taiwan: Identification of a novel frameshift mutation
|
Lin, L.-I.;Lin, K.-S.;Lin, K.-H.;Chang, H.-C.; KAI-HSIN LIN |
| 臺大學術典藏 |
2018 |
Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA
|
Tien F.-M.; Hou H.-A.; Tang J.-L.; Tien H.-F.; Chou W.-C.; Lin L.-I.; Chen C.-Y.; CHENG-HONG TSAI; Yao M.; Lin C.-T.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Liu J.-H.; Chou S.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Kuo Y.-Y. |
| 臺大學術典藏 |
2018 |
Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA
|
Chou S.-C.; Liu J.-H.; Wu S.-J.; Hsu S.-C.; Ko B.-S.; Li C.-C.; Huang S.-Y.; Lin C.-T.; Yao M.; Tien F.-M.; Hou H.-A.; Tang J.-L.; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2018 |
Hyperleukocytosis is associated with distinct genetic alterations and is an independent poor-risk factor in de novo acute myeloid leukemia patients
|
Tsai C.-H.; Hou H.-A.; Tien F.-M.; HWEI-FANG TIEN; Chou W.-C.; Lin L.-I.; Liu C.-W.; Liu M.-C.; Tang J.-L.; Chen C.-Y.; Kuo Y.-Y.; Li C.-C.; Lin C.-T.; Yao M.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Tsay W.; Tseng M.-H. |
| 臺大學術典藏 |
2018 |
Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome
|
Lin L.-I.; Yao M.; Liao X.-W.; Liu C.-W.; Liu M.-C.; Peng Y.-L.; Tseng M.-H.; Liu C.-Y.; Kuo Y.-Y.; Chou W.-C.; Lin C.-C.; Tsai C.-H.; Hou H.-A.; Tang J.-L.; HWEI-FANG TIEN |
| 臺大學術典藏 |
2018 |
Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA
|
Tang J.-L.; Hou H.-A.; Tien F.-M.; Tien H.-F.; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; MING YAO; Lin C.-T.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Wu S.-J.; Liu J.-H.; Chou S.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C. |
| 臺大學術典藏 |
2018 |
Incorporation of mutations in five genes in the revised International Prognostic Scoring System can improve risk stratification in the patients with myelodysplastic syndrome
|
Liao X.-W.; Lin L.-I.; Liu C.-W.; Liu M.-C.; Peng Y.-L.; Tseng M.-H.; Liu C.-Y.; Kuo Y.-Y.; Chou W.-C.; Lin C.-C.; Tsai C.-H.; Hou H.-A.; MING YAO; Tang J.-L.; Tien H.-F. |
| 臺大學術典藏 |
2017 |
Clinico-biological significance of suppressor of cytokine signaling 1 expression in acute myeloid leukemia
|
Tang J.-L.; Gong Z.; Lin L.-I.; Tien H.-F.; Peng Y.-L.; Tseng M.-H.; Chiang Y.-C.; Liu C.-Y.; Kuo Y.-Y.; Lin C.-C.; Chou W.-C.; CHENG-HONG TSAI; Lu J.-W.; Lin T.-Y.; Hou H.-A. |
| 臺大學術典藏 |
2017 |
Prognostic impacts and dynamic changes of cohesin complex gene mutations in de novo acute myeloid leukemia
|
Lin C.-C.; Chiu Y.-C.; Kuo Y.-Y.; Tang J.-L.; Hou H.-A.; Tsai C.-H.; HWEI-FANG TIEN; Chou W.-C.; Chuang E.Y.; Tsay W.; Chen C.-Y.; Liu C.-Y.; Tseng M.-H.; Lin T.-Y.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Yao M.; Li C.-C.; Huang S.-Y.; Ko B.-S.; Hsu S.-C.; Lin C.-T.; Wu S.-J. |
| 臺大學術典藏 |
2017 |
Distinct molecular genetics of chronic lymphocytic leukemia in Taiwan: Clinical and pathogenetic implications
|
Ghia P.; HWEI-FANG TIEN; Kuo Y.-Y.; Lin L.-I.; Lin C.-T.; Agathangelidis A.; Wu S.-J. |
| 臺大學術典藏 |
2017 |
Distinct molecular genetics of chronic lymphocytic leukemia in Taiwan: Clinical and pathogenetic implications
|
Agathangelidis A.; Lin C.-T.; SHANG-JU WU; Lin L.-I.; Kuo Y.-Y.; Tien H.-F.; Ghia P. |
| 臺大學術典藏 |
2017 |
Overexpression of SOX4 correlates with poor prognosis of acute myeloid leukemia and is leukemogenic in zebrafish
|
Lin L.-I.; Chen C.-Y.; HWEI-FANG TIEN; Hsieh M.-S.; Hou H.-A.; Lu J.-W. |
| 臺大學術典藏 |
2017 |
Prognostic impacts and dynamic changes of cohesin complex gene mutations in de novo acute myeloid leukemia
|
Tsai C.-H.; Hou H.-A.; Tang J.-L.; Kuo Y.-Y.; Chiu Y.-C.; Lin C.-C.; Liu C.-Y.; Tseng M.-H.; Lin T.-Y.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Yao M.; Li C.-C.; SHANG-YI HUANG; Ko B.-S.; Hsu S.-C.; Lin C.-T.; Wu S.-J.; Chen C.-Y.; Tsay W.; Chuang E.Y.; Chou W.-C.; Tien H.-F. |
| 國立臺灣大學 |
2016 |
MUTATIONS OF COHESIN COMPLEX GENES IN MYELODYSPLASTIC SYNDROME: DISTINCT CLINIC-BIOLOGICAL FEATURES AND PROGNOSTIC RELEVANCE
|
Chen, L. H.; Hou, H. A.; Chou, W. C.; Kuo, Y. Y.; Tang, J. L.; Liu, C. Y.; Lin, C. C.; Tseng, M. H.; Chiang, Y. C.; Liu, M. C.; Liu, C. W.; Lin, L. I.; Tsay, W.; Yao, M.; Li, C. C.; Huang, S. Y.; Ko, B. S.; Hsu, S. C.; Chen, C. Y.; Lin, C. T.; Wu, S. J.; Tien, H. F.; 林建嶔; 林吉崇; 蔡偉; 林亮音; 姚明; 陳建源; 柯博升; 田蕙芬; 劉敏枝; 郭遠燁; 黃聖懿; 吳尚儒; 唐季祿; 周文堅; 侯信安 |
| 國立臺灣大學 |
2016 |
Genetic alterations and their clinical implications in older patients with acute myeloid leukemia
|
Tsai, C-H; Hou, H-A; Tang, J-L; Liu, C-Y; Lin, C-C; Chou, W-C; Tseng, M-H; Chiang, Y-C; Kuo, Y-Y; Liu, M-C; Liu, C-W; Lin, L-I; Tsay, W.; Yao, M.; Li, C-C; Huang, S-Y; Ko, B-S; Hsu, S-C; Chen, C-Y; Lin, C-T; Wu, S-J; Tien, H-F; 林建嶔; 林吉崇; 蔡偉; 林亮音; 姚明; 陳建源; 柯博升; 徐思淳; 田蕙芬; 劉敏枝; 郭遠燁; 黃聖懿; 吳尚儒; 唐季祿; 周文堅; 侯信安 |
| 國立臺灣大學 |
2016 |
BOTANICAL ALKYL HYDROQUINONE HQ17(3) INDUCES ENDOPLASMIC-RETICULUM STRESS AND AUTOPHAGY BEFORE THE ONSET OF CYTOTOXICITY ON THE T(9;22) PHILADELPHIA CHROMOSOME POSITIVE SUP-B15 ALL CELLS
|
Chen, C. W.; Chang, Y. J.; Lin, L. I.; Lin, D. T.; Hu, C. Y.; 林東燦; 林亮音; 胡忠怡 |
| 國立臺灣大學 |
2016 |
MYELOID-SPECIFIC EXPRESSION OF SOX4 INDUCES EXPANDED MYELOPOIESIS WITH RETARDED CELL DIFFERENTIATION - A NOVEL ZEBRAFISH LEUKEMIA MODEL
|
Lin, L. I.; Lu, J. W.; Hsieh, M. S.; Hou, H. A.; Chen, C. Y.; Tien, H. F.; 林亮音; 陳建源; 田蕙芬; 侯信安 |
| 國立臺灣大學 |
2016 |
NPM1 MUTATION AND FLT3/ITD IN A DOUBLE TRANSGENIC ZEBRAFISH RECAPITULATES FEATURES OF HUMAN ACUTE MYELOID LEUKEMIA
|
Lu, J. W.; Hou, H. A.; Hsieh, M. S.; Tien, H. F.; Lin, L. I.; 林亮音; 田蕙芬; 侯信安 |
